Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
| (8 intermediate revisions by 2 users not shown) | |||
| Line 9: | Line 9: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
| − | *[[Media: | + | *[[Media:2020_08-11_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | August 11, 2020]] |
| − | *[[Media: | + | *[[Media:2020_05-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | May 12, 2020]] |
| − | *[[Media: | + | *[[Media:2020_04-14_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | April 14, 2020]] |
| + | *[[Media:2020_03-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | March 10, 2020]] | ||
'''''[[SPECT TC99m BC Call Summaries Archive]]''''' | '''''[[SPECT TC99m BC Call Summaries Archive]]''''' | ||
Revision as of 14:34, 13 August 2020
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- RSNA Staff Support: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology
Recent Meetings/Call Summaries
SPECT TC99m BC Call Summaries Archive